[Photo by Yonhap]
A global universal regulatory framework and sustained investment are deemed essential to address potential challenges arising from “next pandemic,” according to global health experts.
During the World Bio Summit 2023 organized by the Ministry of Health and Welfare and the World Health Organization (WHO) in Seoul on Tuesday, experts in infectious disease vaccines and treatments gathered to emphasize the necessity of global cooperation.
The collaboration spans various aspects, from value chains and regulations to investments, aimed at preparing for future pandemics.
“Throughout the Covid-19 pandemic, we have observed that country-specific regulations could hinder responses to novel pandemics,” said Muk Hyun-sang, president of the Korea Drug Development Fund. “Approval from regulatory authorities is crucial for the use of infectious disease treatments and vaccines, but regulations vary by country. Therefore, it is necessary to consider ways to harmonize them.”
Experts also underscored the importance of sustained investment, arguing that government support is essential for private companies engaging in investments related to infectious diseases.
“We had to make sacrifices in our main business of biosimilars as we developed and produced the Covid-19 treatment, Regkirona,” said Celltrion Inc. Senior Managing Director Lee Soo-young. “Government-level investment should remain consistent since it is impossible to predict when the next pandemic will occur,” Lee added.
Experts also called for securing clear data on the established global infrastructure for infectious disease treatments and vaccines worldwide to better prepare for future challenges.
By Kim Jee-hee and Chang Iou-chung
[ⓒ Pulse by Maeil Business Newspaper & mk.co.kr, All rights reserved]